Oxford Immunotec Global PLC 4 SEC Filings

Filed On	Filing
12 Mar 2021	Form 4: Rosenman Herm, Director Returned 4,081 shares to the issuer ($89.8K) · Disposed of 76,607 Stock Option (Right to Buy) (Disposition to Issuer) ($598K)
12 Mar 2021	Form 4: McLaughlin Matthew T E, Chief Financial Officer Returned 61,407 shares to the issuer ($1.35M) · Disposed of 91,903 Stock Option (Right to Buy) (Disposition to Issuer) ($686K)
12 Mar 2021	Form 4: Sandberg Richard A, Director Returned 4,081 shares to the issuer ($89.8K) · Disposed of 52,886 Stock Option (Right to Buy) (Disposition to Issuer) ($433K)
12 Mar 2021	Form 4: Klausner Mark R., Director Returned 4,081 shares to the issuer ($89.8K) · Disposed of 43,050 Stock Option (Right to Buy) (Disposition to Issuer) ($405K)
12 Mar 2021	Form 4: Kidd Janet Louise, General Counsel Returned 11,207 shares to the issuer ($247K) · Disposed of 23,290 Stock Option (Right to Buy) (Disposition to Issuer) ($123K)
12 Mar 2021	Form 4: Randall Patricia, Director Returned 27,805 shares to the issuer ($612K) · Disposed of 91,391 Stock Option (Right to Buy) (Disposition to Issuer) ($1.01M)
12 Mar 2021	Form 4: Balthrop Patrick J, Director Returned 8,081 shares to the issuer ($178K) · Disposed of 57,964 Stock Option (Right to Buy) (Disposition to Issuer) ($547K)
12 Mar 2021	Form 4: Walton Andrew Scott, Director Returned 4,081 shares to the issuer ($89.8K) · Disposed of 61,693 Stock Option (Right to Buy) (Disposition to Issuer) ($567K)
12 Mar 2021	Form 4: Wrighton-Smith Peter, Director Returned 400,225 shares to the issuer ($8.8M) · Disposed of 560,924 Stock Option (Right to Buy) (Disposition to Issuer) ($5.02M)
12 Mar 2021	Form 4: Andrews Ronald Asbury, Director Returned 4,081 shares to the issuer ($89.8K) · Disposed of 61,693 Stock Option (Right to Buy) (Disposition to Issuer) ($567K)
12 Mar 2021	Form 4: Tobin James R, Director Returned 4,081 shares to the issuer ($89.8K) · Disposed of 69,150 Stock Option (Right to Buy) (Disposition to Issuer) ($613K)
26 Jun 2020	Form 4: Andrews Ronald Asbury, Director Received 4,081 shares as a grant or award · Granted 9,494 Share Option (Right to Buy)
26 Jun 2020	Form 4: Balthrop Patrick J, Director Received 4,081 shares as a grant or award · Granted 9,494 Share Option (Right to Buy)
26 Jun 2020	Form 4: Klausner Mark R., Director Received 4,081 shares as a grant or award · Granted 9,494 Share Option (Right to Buy)
26 Jun 2020	Form 4: Randall Patricia, Director Received 4,081 shares as a grant or award · Granted 9,494 Share Option (Right to Buy)
26 Jun 2020	Form 4: Rosenman Herm, Director Received 4,081 shares as a grant or award · Granted 9,494 Share Option (Right to Buy)
26 Jun 2020	Form 4: Sandberg Richard A, Director Received 4,081 shares as a grant or award · Granted 9,494 Share Option (Right to Buy)
26 Jun 2020	Form 4: Tobin James R, Director Received 4,081 shares as a grant or award · Granted 9,494 Share Option (Right to Buy)
26 Jun 2020	Form 4: Walton Andrew Scott, Director Received 4,081 shares as a grant or award · Granted 9,494 Share Option (Right to Buy)
21 May 2020	Form 4: Balthrop Patrick J, Director Bought 4,000 shares ($49.9K)

Comments